TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3332574

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (30 mg, 60 mg, or 90 mg once daily)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Long-acting propranolol (80 mg, 160 mg, or 240 mg once daily)
Number of subjects: 49
Study: 30640688

Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic surgery (RALS)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 96
Study: 28218596

Group type: EXPERIMENTAL
Intervention: Forced aerobic exercise
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Voluntary aerobic exercise
Number of subjects: 17

Group type: COMPARATOR
Intervention: Repetitive task practice only
Number of subjects: 17
Study: 26449739

Group type: EXPERIMENTAL
Intervention: Rituximab maintenance therapy (375 mg/m² every 3 months for 2 years)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 321
Study: 23949063

Group type: EXPERIMENTAL
Intervention: Inpatient multidisciplinary rehabilitation
Number of subjects: 19
Study: 21497851

Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA 300 U
Number of subjects: 57

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 57
Study: 19338146

Group type: EXPERIMENTAL
Intervention: Shenfu Injection (SFI) pre-treated group
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Shenfu Injection (SFI) post-treated group
Number of subjects: 133

Group type: COMPARATOR
Intervention: Shenfu Injection (SFI)
Number of subjects: 133
Study: 16738348

Group type: EXPERIMENTAL
Intervention: Group interpersonal psychotherapy
Number of subjects: 0
Study: 16145898

Group type: EXPERIMENTAL
Intervention: Astragali injection
Number of subjects: 60
Study: 9065192

Group type: EXPERIMENTAL
Intervention: Verbal group (individualized education program)
Number of subjects: 1275

Group type: COMPARATOR
Intervention: Document group (pamphlet detailing benefits of vaginal birth after cesarean)
Number of subjects: 1275
Study: 8311029

Group type: EXPERIMENTAL
Intervention: 12-session parenting intervention program
Number of subjects: 70

Group type: COMPARATOR
Intervention: wait-list condition
Number of subjects: 70
Study: 3015809

Group type: EXPERIMENTAL
Intervention: Activated charcoal (50 g) given within 5 min of amitriptyline (75 mg) dose
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Activated charcoal (50 g followed by 12.5 g at 6-h intervals)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Urine pH acidification to 4
Number of subjects: 6
Study: 30851620

Group type: EXPERIMENTAL
Intervention: HaRT-A
Number of subjects: 168

Group type: COMPARATOR
Intervention: Services as usual
Number of subjects: 168
Study: 28425307

Group type: EXPERIMENTAL
Intervention: Epidural ropivacaine 0.2% combined with fentanyl 20μg (F/R-group, n=31)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Epidural ropivacaine 0.2% (R-group, n=31)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Epidural ropivacaine 0.2% combined with fentanyl 20μg (F/R-group)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Epidural ropivacaine 0.2% (R-group)
Number of subjects: 62
Study: 25239553

Group type: EXPERIMENTAL
Intervention: GI Mentor simulator
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both simulators (GI Mentor and Kyoto)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Kyoto simulator
Number of subjects: 27
Study: 23321224

Group type: EXPERIMENTAL
Intervention: 0.5 mg dexamethasone
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: 400 mg ibuprofen
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo (lactose powder)
Number of subjects: 165
Study: 21077943

Group type: EXPERIMENTAL
Intervention: Orlistat plus L‐carnitine
Number of subjects: 258

Group type: COMPARATOR
Intervention: Orlistat alone
Number of subjects: 258
Study: 19380188

Group type: EXPERIMENTAL
Intervention: Bipolar vessel sealing system (BVSS)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional suture ligature
Number of subjects: 90
Study: 16963828

Group type: EXPERIMENTAL
Intervention: Subanesthetic ketamine infusion (0.5 mg/kg/h)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 58
Study: 15146395

Group type: EXPERIMENTAL
Intervention: Randomized controlled studies (RCTs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naturalistic studies
Number of subjects: 0
Study: 11392465

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Losartan 150 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Candesartan 32 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 9589227

Group type: EXPERIMENTAL
Intervention: Metformin 1 g b.i.d. for 12 weeks
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Metformin at baseline dosage (1-2.5 g) for 12 weeks
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combined data from both studies (n = 33)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 33
Study: 8181589

Group type: EXPERIMENTAL
Intervention: Systemic chemotherapy
Number of subjects: 0
Study: 2548553

Group type: EXPERIMENTAL
Intervention: Cilazapril 5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cilazapril 10 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cilazapril 20 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cilazapril
Number of subjects: 12
Study: 780059

Group type: EXPERIMENTAL
Intervention: Indoramin (125 mg to 200 mg daily)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Indoramin
Number of subjects: 39
Study: 28279119

Group type: EXPERIMENTAL
Intervention: Amnioinfusion with a 500-mL saline solution before the second ECV attempt
Number of subjects: 119

Group type: COMPARATOR
Intervention: ECV only (no amnioinfusion)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Amnioinfusion group
Number of subjects: 119
Study: 28449972

Group type: EXPERIMENTAL
Intervention: Paracetamol (prophylactic)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paracetamol (therapeutic)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No paracetamol
Number of subjects: 0
Study: 26028261

Group type: EXPERIMENTAL
Intervention: Integrated self-care intervention (education and counseling on combined HF and DM self-care with follow-up home visit and telephone counseling)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Usual care (standard HF and DM educational brochures with follow-up telephone contact)
Number of subjects: 134
Study: 24156702

Group type: EXPERIMENTAL
Intervention: EPO (300 IU/kg intravenously after anesthetic induction)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control (normal saline equivalent volume)
Number of subjects: 98
Study: 21050700

Group type: EXPERIMENTAL
Intervention: Postoperative stocking system (Sigvaris Postoperative Kit; 23 to 32 mmHg at the ankle)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard stretch bandages
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Postoperative stocking system (Sigvaris Postoperative Kit)
Number of subjects: 60
Study: 18501431

Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam (9 g every 8h)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Colistin (3 MIU every 8h)
Number of subjects: 28
Study: 16543097

Group type: EXPERIMENTAL
Intervention: Posterior approach (Pippa)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Lateral approach (Winnie)
Number of subjects: 80
Study: 15189625

Group type: EXPERIMENTAL
Intervention: Subliminal exposure to a source
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Explicit exposure to a source
Number of subjects: 0

Group type: COMPARATOR
Intervention: No exposure to a source
Number of subjects: 0
Study: 11099714

Group type: EXPERIMENTAL
Intervention: Piracetam 1600 mg t.i.d.
Number of subjects: 563

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) 200 mg t.i.d.
Number of subjects: 563
Study: 9663835

Group type: EXPERIMENTAL
Intervention: lansoprazole 15 mg daily
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: lansoprazole 30 mg daily
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: lansoprazole (both doses)
Number of subjects: 103
Study: 8230148

Group type: EXPERIMENTAL
Intervention: Extensive Intervention (EI)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Aggregate Intervention (AI)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Limited Intervention (LI)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 85
Study: 3786999

Group type: EXPERIMENTAL
Intervention: Dose-finding trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 29978223

Group type: EXPERIMENTAL
Intervention: POCUS
Number of subjects: 64

Group type: COMPARATOR
Intervention: Non-POCUS
Number of subjects: 64
Study: 27680411

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine-enhanced liver magnetic resonance (MR) after transcatheter arterial chemoembolization (TACE)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine-enhanced liver magnetic resonance (MR)
Number of subjects: 45
Study: 24768595

Group type: EXPERIMENTAL
Intervention: Interactive educational session, clinician reminders, and individualized feedback
Number of subjects: 6

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 6
Study: 24247995

Group type: EXPERIMENTAL
Intervention: Tele-rehabilitation intervention (specific details not provided)
Number of subjects: 111
Study: 20085546

Group type: COMPARATOR
Intervention: NaCl 0.9% (placebo)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% (RO2.0)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75% (RO7.5)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% (BU2.5)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: All local anesthetics (RO2.0, RO7.5, BU2.5)
Number of subjects: 280
Study: 18230021

Group type: EXPERIMENTAL
Intervention: Narrative evidence (personal account)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Statistical evidence (abstract prevalence data)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Mere assertion of increased risk
Number of subjects: 118

Group type: COMPARATOR
Intervention: No risk information
Number of subjects: 118
Study: 16628140

Group type: EXPERIMENTAL
Intervention: Ketoconazole (200 mg orally twice per day for 3 days)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Midazolam (2.5 mg and 1 mg intravenously)
Number of subjects: 57
Study: 12556655

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Losartan 50 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Valsartan 80 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 0
Study: 10953181

Group type: EXPERIMENTAL
Intervention: Electrographic seizures (ESz) in neonates
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no ESz)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Subgroup of infants with asphyxia and ESz
Number of subjects: 68
Study: 9219144

Group type: EXPERIMENTAL
Intervention: Active zones (Shenmen, Liver, Lung, and Sympathetic)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control zones (located on the ear helix)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Needles inserted into points of low electrical resistance in one ear and high electrical resistance in the other
Number of subjects: 34
Study: 1486974

Group type: EXPERIMENTAL
Intervention: Inhaled glucocorticosteroid, budesonide 400 micrograms b.i.d.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3721055

Group type: EXPERIMENTAL
Intervention: Intramuscular buprenorphine (0.3 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intramuscular combination of buprenorphine (0.3 mg)/naloxone (0.2 mg)
Number of subjects: 60
Study: 31615892

Group type: EXPERIMENTAL
Intervention: Capitalist managers
Number of subjects: 268239

Group type: COMPARATOR
Intervention: Workers without a capitalist class advantage
Number of subjects: 268239
Study: 29959929

Group type: EXPERIMENTAL
Intervention: Video presentation during physician counseling
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard physician counseling (control arm)
Number of subjects: 120
Study: 27169564

Group type: EXPERIMENTAL
Intervention: Olaparib 200 mg tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olaparib 300 mg tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olaparib 400 mg tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Olaparib 300 mg and 400 mg tablets
Number of subjects: 0
Study: 25236873

Group type: EXPERIMENTAL
Intervention: Highest triglycerides/HDL-C ratio quintile
Number of subjects: 3680

Group type: EXPERIMENTAL
Intervention: Highest total cholesterol/HDL-C ratio quintile
Number of subjects: 3680
Study: 23250168

Group type: EXPERIMENTAL
Intervention: Metal bracket + LED cured
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ceramic bracket + LED cured
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Metal bracket + plasma arc cured
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ceramic bracket + plasma arc cured
Number of subjects: 60
Study: 20113414

Group type: EXPERIMENTAL
Intervention: 8% lidocaine spray
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: lidocaine patch
Number of subjects: 13

Group type: COMPARATOR
Intervention: no application (control)
Number of subjects: 13
Study: 18677174

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 34

Group type: COMPARATOR
Intervention: Rosiglitazone (8 mg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study: 16816482

Group type: EXPERIMENTAL
Intervention: Active vitamin D3 therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of Active vitamin D3 and bisphosphonates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bisphosphonates
Number of subjects: 0
Study: 12496225

Group type: EXPERIMENTAL
Intervention: Recombinant erythropoietin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham treatment (Control)
Number of subjects: 0
Study: 9952390

Group type: EXPERIMENTAL
Intervention: Standard-dose ivermectin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High-dose ivermectin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 8603281

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hydroxyzine 50 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Diphenhydramine 50 mg
Number of subjects: 20
Study: 2337571

Group type: EXPERIMENTAL
Intervention: 5% eutectic mixture of lignocaine (100 mg) and prilocaine (100 mg) plus emulsifier (EMLA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10% lignocaine spray (200 mg)
Number of subjects: 0
Study: 79707

Group type: EXPERIMENTAL
Intervention: Doppler ultrasound
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Impedance plethysmography
Number of subjects: 207

Group type: COMPARATOR
Intervention: Venography
Number of subjects: 207
Study: 31902129

Group type: EXPERIMENTAL
Intervention: Nordic Hamstring Exercise
Number of subjects: 259

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 259
Study: 31107396

Group type: EXPERIMENTAL
Intervention: Values affirmation
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Parenting affirmation
Number of subjects: 237

Group type: COMPARATOR
Intervention: Control (no affirmation)
Number of subjects: 237
Study: 28446764

Group type: EXPERIMENTAL
Intervention: Recombination hot regions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presence of genes and DNA transposons
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presence of long terminal repeat retrotransposons
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fine-mapped recombination hot regions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-resolution genotyping of five randomly selected regions
Number of subjects: 0
Study: 26001948

Group type: EXPERIMENTAL
Intervention: Zoledronate 5 mg intravenous infusion
Number of subjects: 2001

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2001
Study: 23900920

Group type: EXPERIMENTAL
Intervention: Minimally invasive plate osteosynthesis (MIPO)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 36
Study: 20602013

Group type: EXPERIMENTAL
Intervention: 10/66 caregiver intervention
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study: 19122264

Group type: EXPERIMENTAL
Intervention: Bisphosphonates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alendronate (extension of trial)
Number of subjects: 0
Study: 16791013

Group type: EXPERIMENTAL
Intervention: Zidovudine/lamivudine/tenofovir DF
Number of subjects: 300
Study: 15038632

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10780755

Group type: EXPERIMENTAL
Intervention: Successful weaning trial
Number of subjects: 81

Group type: COMPARATOR
Intervention: Failed weaning trial
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Threshold values for tidal volume and effective compliance
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Maximal inspiratory pressure (MIP), deltaPI/MIP, respiratory frequency/tidal volume, CROP
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: deltaPI/MIP and CROP
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: occluded inspiratory pressure swing/maximal inspiratory pressure and compliance, rate, oxygenation, pressure index (CROP)
Number of subjects: 81
Study: 9432896

Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural anesthesia with 20 mg of 1% lidocaine and maintained with 2% lidocaine through an epidural catheter (Group I)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Spinal plain 20 mg of 0.5% bupivacaine (Group II)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Initial dose of plain 0.5% bupivacaine 3 ml (15 mg) with an incremental dose of 3 ml (15 mg) (Group III)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Use of epidural catheter during surgery (Group II)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Use of epidural catheter during surgery (Group III)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Total dose of anesthetic (Group I)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Total dose of anesthetic (Group II)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Total dose of anesthetic (Group III)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Arterial pressure drop (Group I)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Arterial pressure drop (Group II)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Arterial pressure drop (Group III)
Number of subjects: 38
Study: 7871065

Group type: EXPERIMENTAL
Intervention: Three IM morphine injections (18 mg/70 kg) spaced at 12-h intervals
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Three IM morphine injections (18 mg/70 kg) spaced at 24-h intervals
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Three IM morphine injections (18 mg/70 kg) spaced at 48-h intervals
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Three IM morphine injections (18 mg/70 kg) spaced at 72-h intervals
Number of subjects: 10

Group type: COMPARATOR
Intervention: Single IM morphine pretreatment (18 mg/70 kg) followed by naloxone challenge (10 mg/70 kg IM)
Number of subjects: 10
Study: 2878712

Group type: EXPERIMENTAL
Intervention: Bethanechol chloride (Urecholine) infused intracerebroventricularly with an Infusaid continuous infusion pump
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 29255066

Group type: EXPERIMENTAL
Intervention: Chemoimmunotherapy
Number of subjects: 1204

Group type: EXPERIMENTAL
Intervention: PB-MRD as a primary end point in randomized clinical trials of chemoimmunotherapy in CLL
Number of subjects: 1204
Study: 27464461

Group type: EXPERIMENTAL
Intervention: Freeze-dried strawberry powder (FDSP) 50 g daily for 1 week
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control powder
Number of subjects: 25
Study: 24981605

Group type: EXPERIMENTAL
Intervention: Medication reconciliation performed at discharge by a hospital pharmacist with communication to the community pharmacist.
Number of subjects: 1176

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 1176
Study: 22014959

Group type: EXPERIMENTAL
Intervention: Active swallowing exercises (pharyngocise)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sham swallowing intervention
Number of subjects: 58
Study: 20863237

Group type: EXPERIMENTAL
Intervention: Desensitizer toothpaste and GaAlAs (diode) laser therapy
Number of subjects: 13

Group type: COMPARATOR
Intervention: Desensitizer toothpaste
Number of subjects: 13
Study: 18794896

Group type: EXPERIMENTAL
Intervention: Ileal fat perfusion (3 g and 9 g safflower oil)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ileal placebo infusion after fat-free liquid breakfast (treatment C)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Fat-free liquid breakfast
Number of subjects: 16
Study: 17119044

Group type: EXPERIMENTAL
Intervention: Video-based information study arm
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Print-based information study arm
Number of subjects: 238

Group type: COMPARATOR
Intervention: Wait list control study arm
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Both interventions (video and print)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Exploratory analysis
Number of subjects: 238
Study: 12139807

Group type: EXPERIMENTAL
Intervention: NPTS with reticulated hyaluronic acid implant
Number of subjects: 168

Group type: COMPARATOR
Intervention: Traditional trabeculectomy
Number of subjects: 168
Study: 11563408

Group type: EXPERIMENTAL
Intervention: Ganciclovir 2000 mg tid taken within 30 minutes of a meal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ganciclovir 2000 mg tid taken on an empty stomach
Number of subjects: 0
Study: 8541005

Group type: EXPERIMENTAL
Intervention: 5 mg amlodipine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 10 mg felodipine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 2031393

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 40 mcg prostaglandin E1
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48